Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment
Jill K. Wieser(University of Rochester Medicine), Lisa A. Beck(University of Rochester Medicine), Gina J. Kuehn(University of Rochester Medicine), Jane L. Liesveld(Strong Memorial Hospital), Glynis Scott(University of Rochester Medical Center), James C. Prezzano(University of Rochester Medicine), Julia D. Stiegler(University of Rochester Medicine), Elizabeth Cusick(University of Rochester Medicine)
Cited by 17
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Cytokine modulation of atopic dermatitis filaggrin skin expression
|Journal of Allergy and Clinical Immunology|2007|1.1k